Drug Interactions between Calci-Chew and lansoprazole
This report displays the potential drug interactions for the following 2 drugs:
- Calci-Chew (calcium carbonate)
- lansoprazole
Interactions between your drugs
No interactions were found between Calci-Chew and lansoprazole. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Calci-Chew
A total of 223 drugs are known to interact with Calci-Chew.
- Calci-chew is in the following drug classes: antacids, minerals and electrolytes.
- Calci-chew is used to treat the following conditions:
lansoprazole
A total of 206 drugs are known to interact with lansoprazole.
- Lansoprazole is in the drug class proton pump inhibitors.
-
Lansoprazole is used to treat the following conditions:
- Aspiration Pneumonia (off-label)
- Barrett's Esophagus
- Duodenal Ulcer
- Duodenal Ulcer Prophylaxis
- Erosive Esophagitis
- Gastritis/Duodenitis
- GERD
- Helicobacter Pylori Infection
- Hiatal Hernia
- Laryngopharyngeal Reflux (off-label)
- Multiple Endocrine Adenomas
- NSAID-Induced Gastric Ulcer
- NSAID-Induced Ulcer Prophylaxis
- Stomach Ulcer
- Systemic Mastocytosis
- Zollinger-Ellison Syndrome
Drug and food interactions
calcium carbonate food
Applies to: Calci-Chew (calcium carbonate)
ADJUST DOSING INTERVAL: Administration with food may increase the absorption of calcium. However, foods high in oxalic acid (spinach or rhubarb), or phytic acid (bran and whole grains) may decrease calcium absorption.
MANAGEMENT: Calcium may be administered with food to increase absorption. Consider withholding calcium administration for at least 2 hours before or after consuming foods high in oxalic acid or phytic acid.
References (6)
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Canadian Pharmacists Association (2006) e-CPS. http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink
- Cerner Multum, Inc. "Australian Product Information."
- Agencia Española de Medicamentos y Productos Sanitarios Healthcare (2008) Centro de información online de medicamentos de la AEMPS - CIMA. https://cima.aemps.es/cima/publico/home.html
- Mangels AR (2014) "Bone nutrients for vegetarians." Am J Clin Nutr, 100, epub
- Davies NT (1979) "Anti-nutrient factors affecting mineral utilization." Proc Nutr Soc, 38, p. 121-8
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.